Company: PCRX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001396814-25-000041
Chunk: 57

Company: Pacira BioSciences, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 57
---
 agency, government and Yankee bonds with maturities greater than three months, but less than one year. Noncurrent investments consist of asset-backed securities collateralized by credit card receivables and contain maturities greater than one year but less than three years. Net unrealized gains and losses (excluding credit losses, if 

Pacira BioSciences, Inc.  |  2024 Annual Report on Form 10-K  |  Page F-30

Table of ContentsPACIRA BIOSCIENCES, INC.NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

any) from the Company’s short-term investments are reported in other comprehensive (loss) income. At December 31, 2024 and 2023, all of the Company’s short-term and noncurrent investments are classified as available-for-sale investments and are determined to be Level 2 instruments, with the exception of U.S. government bonds, which are measured at fair value using standard industry models with observable inputs. The fair value of the commercial paper is measured based on a standard industry model that uses the three-month U.S. Treasury bill rate as an observable input. The fair value of the asset-backed securities and corporate bonds is principally measured or corroborated by trade data for identical issues in which related trading activity is not sufficiently frequent to be considered a Level 1 input or that of comparable securities. The fair value of U.S. government bonds is based on level 1 trading activity. At the time of purchase, all available-for-sale investments had an “A” or better rating by Standard & Poor’s.The following summarizes the Company’s available-for-sale investments at December 31, 2024 and 2023 (in thousands):December 31, 2024 Investments:CostGrossUnrealizedGainsGrossUnrealizedLossesFair Value(Level 2)Current:Asset-backed securities$21,626 $43 $— $21,669 Commercial paper142,556 120 (55)142,621 Corporate bonds32,502 25 (5)32,522 U.S. federal agency bonds5,996 8 — 6,004 Yankee bond5,012 13 — 5,025 Total$207,692 $209 $(60)$207,841 December 31, 2023 Investments:CostGrossUnrealizedGainsGrossUnrealizedLossesFair Value(Level 1